Champions Oncology (CSBR) Receivables - Net (2011 - 2026)

Champions Oncology's Receivables - Net history runs 16 years deep, the most recent figure standing at $12.1 million for Q1 2026.

• In Q1 2026, Receivables - Net fell 23.54% year-over-year to $12.1 million; the TTM figure through Jan 2026 stood at $12.1 million (down 23.54% YoY), while the FY2025 annual figure was $11.2 million, up 17.61% from the prior year.
• Receivables - Net was $12.1 million for Q1 2026 at Champions Oncology, up from $5.4 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $15.8 million in Q1 2025 to a low of $5.4 million in Q4 2025.
• Historically, Receivables - Net has averaged $9.6 million across 5 years, with a median of $9.4 million in 2022.
• Biggest YoY gain for Receivables - Net was 74.71% in 2025; the steepest drop was 48.61% in 2025.
• A 5-year view of Receivables - Net shows it stood at $9.0 million in 2022, then declined by 14.44% to $7.7 million in 2023, then soared by 35.97% to $10.5 million in 2024, then sank by 48.61% to $5.4 million in 2025, then surged by 124.25% to $12.1 million in 2026.
• The last three Receivables - Net figures came in at $12.1 million (Q1 2026), $5.4 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.